0130989-200805250-00019.pdf

PAGE 54 / MAY 25, 2008
S C R I P T D O C T O R : M E D I C I N E I N T H E M E D I A
Dateline Nigeria (Part 3):
Creating Solutions When Despite Public Service Announcements, Ads, & Documentaries, Many Women Were Still Not Seeking Life-Saving Treatment that was created aftera well-meaning health Andrew Holtz, MPH, is a
“Sànnu.”
former CNN Medical
Correspondent and the author
of “The Medical Science of
House, M.D.” Send questions
to him about how the media
treat medical topics or
suggestions for future columns
patients don’t seem to really hear what to [email protected]
Nigeria have obstetric fistulae. To try to clinics to repair the holes and alleviate the related incontinence, infections, and then together sketched out a story arc.
As a result, radio listeners heard stories the focus on what’s relevant and inter- variety show Ya Take Ne (What’s Up?).
regime in Kano state say ‘sex,’” she without saying ‘sex’? She said you talk Putting Storytelling First
those who tuned in to Gugar Goge were by the program,” Christine K said.
Parts I and 2 of this series
appeared in the April 25
and May 10 issues.
a radio soap opera called Gugar Goge (Tell Me Straight). Rather than building with anastrozole,” Dr. Singh said.
Bisphosphonates
Oral vs. IV
ty as detected in imaging studies or if a group, there was not a “big difference” oncologists tend to reach for oral bispho- significantly greater with anastrozole,” of osteoporosis, albeit outside of the con- significant difference of 6.7% in favor of the upfront group, Dr. Brufsky reported.
porosis, “they are not always well toler- PAGE 55 / MAY 25, 2008
IP Therapy Still Overlooked for Ovarian Cancer
Issues of toxicity and complexity continue to concern clinicians in deciding about using Dedrick, PhD, et al published in CancerTherapy Reports indicating that certain NEW YORK CITY—Issues of tox-
icity and complexity continue tocause intraperitoneal therapy tobe overlooked by clinicians in intraperitoneal therapy for ovarian cancer. overall survival. So said presenters here Symposium in discussions that re-viewed the latest therapeutic research.
nique, Maurie Markman, MD, VicePresident for Clinical Research andProfessor and Chair of GynecologicMedical Oncology at the University ofTexas M. D. Anderson Cancer Center,noted that since ovarian cancer mostlyremains confined to the peritoneal cav-ity, researchers in the early 1950s intro-duced the idea of administering che-motherapy intraperitoneally. However, ScriptDoctor
continued from page 54
pregnancy carries health risks forwomen.
‘See the Characters as
Human Beings’
“One striking thing that surprises meevery day is that people can actuallyidentify our characters, people canactually tell you the circumstances, peo-ple see the characters as humanbeings,” Asangaeneng said, adding thatthe characters have become role mod-els, their names entering everyday con-versations.
sometimes even has consequences forthe actors.
during a [Population Media Center]program,” Asangaeneng recalled, “theactor of a particular character that wasagainst gender equity was pelted withtomatoes by women in the market,because they believed his actions werereal. They never even considered hewas [acting] in the context of a drama.”

Source: http://holtzreport.com/thescriptdoctor/columns/Dateline_Nigeria__Part_3___Creating_Solutions_When.19.pdf

pep.chapsonline.org.uk

As drug-resistant HIV strains become What would need to change more common it will increasingly if PEP for sexual exposure 1. HIV Post-Exposure Prophylaxis: Guidance from impact on PEP’s effectiveness and was to become more widely the UK Chief Medical Officers’ Expert Advisory Group on AIDS (Dept of Health guidelines on PEP the need for resistance-testing of availab

Microsoft word - welcome programme fall semester_full academic year 2011-12.doc

International Office WELCOME PROGRAMME ACADEMIC YEAR Fall Semester / Full academic year students International Office Monday, 12th September Place Salón de Grados (Conference Hall) Julián Romea, 23 – Ground Floor 10:00 h. PRESENTATION OF CEU SAN PABLO UNIVERSITY PROF. LEOPOLDO ABAD ALCALÁ Director of International Programmes PRESENTATION OF INTE

Copyright © 2009-2018 Drugs Today